Award
National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK140904-03
Developing ultrasound contrast agents and signal processing for structural and functional imaging in type 1 diabetes
Recipient
University of Colorado Denver
Award Amount
$632,022.00
Ceiling
$632,022.00
Awarded
June 09, 2026
Identifier
5R01DK140904-03
This NIH-funded project aims to develop novel ultrasound contrast agents and signal processing methods to improve early diagnosis and monitoring of type 1 diabetes by visualizing vascular impairments and targeting inflamed islet microenvironments.
Description
The project focuses on developing and applying advanced ultrasound imaging techniques to detect and monitor type 1 diabetes (T1D). It involves the use of contrast-enhanced ultrasound, microbubbles, nanodrops, and super-resolution imaging to provide image-guided assessment of disease progression and therapeutic efficacy.